• Transthyretin (TTR) Gene Mutation Analysis
  • Lipid Panel
  • 5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations
  • Dihydrocodeine, Urine
  • Inherited Insulin Resistance Syndromes (INSR) Genetic Testing
  • Benzodiazepines, Confirmation, Urine
  • Biopsy, Gallbladder (Cholecystectomy)
  • Beta-amyloid Protein Ratio 1-42/1-40 (QUEST AD-Detectâ„¢, INNOTEST® B-AMYLOID), Plasma
  • Aspergillus (Galactomannan) Antigen, Serum
  • Immunoglobulin Subclass IgG4
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Factor XIII (F13A1) V34L Genetic Variation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Factor XIII (F13A1) V34L Genetic Variation Analysis
Medical Test

References
Access to Factor XIII (F13A1) V34L Genetic Variation Analysis is restricted.